Figure 1.
Correlations of fasting plasma glucose (a) and HbA1c (b) with phagocytic activity in the whole population.
White circles, non-diabetic patients (fasting glucose: r = −0.419, p = 0.058; HbA1c: r = −0.011, p = 0.956); black circles, type 2 diabetic patients (fasting glucose: r = −0.601, p = 0.004; HbA1c: r = −0.506, p = 0.019).
Table 1.
Main clinical characteristics and metabolic data of participants included in the case-control study according to the presence of type 2 diabetes.
Figure 2.
Flow cytometry graphic measuring phagocytic activity in a representative case of type 2 diabetic patient before (a) and after (b) 5-day intensification treatment of blood glucose.
Table 2.
Main clinical characteristics and metabolic data at baseline (day 1) and discharge (day 5) of type 2 diabetic patients (n = 12) included in the interventional study.